Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
3(23%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
4
31%
Ph phase_1
8
62%
Ph phase_3
1
8%

Phase Distribution

8

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
8(61.5%)
Phase 2Efficacy & side effects
4(30.8%)
Phase 3Large-scale testing
1(7.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

13

all time

Status Distribution
Active(5)
Completed(8)

Detailed Status

Completed8
Recruiting3
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
13
Active
3
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 18 (61.5%)
Phase 24 (30.8%)
Phase 31 (7.7%)

Trials by Status

not_yet_recruiting215%
recruiting323%
completed862%

Recent Activity

3 active trials
Showing 5 of 13
not_yet_recruitingphase_1

A Study of VC005 Tablets in Adolescent Subjects With Non-Segmental Vitiligo

NCT07828639
recruitingphase_2

Phase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia Areata

NCT07749716
completedphase_1

Pharmacokinetics of VC005 Tablets in Subjects With Renal Impairment and Normal Renal Function

NCT07551570
completedphase_1

Pharmacokinetics of VC005 Tablets in Subjects With Hepatic Impairment and Normal Hepatic Function

NCT07551557
not_yet_recruitingphase_1

A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia Areata

NCT07762443
View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT07828639Phase 1

A Study of VC005 Tablets in Adolescent Subjects With Non-Segmental Vitiligo

Not Yet Recruiting
NCT07749716Phase 2

Phase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia Areata

Recruiting
NCT07551570Phase 1

Pharmacokinetics of VC005 Tablets in Subjects With Renal Impairment and Normal Renal Function

Completed
NCT07551557Phase 1

Pharmacokinetics of VC005 Tablets in Subjects With Hepatic Impairment and Normal Hepatic Function

Completed
NCT07762443Phase 1

A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia Areata

Not Yet Recruiting
NCT07533851Phase 1

A Food Effect Study of VC005 Tablets in Healthy Adult Subjects.

Completed
NCT07172347Phase 2

Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo

Recruiting
NCT07172360Phase 3

Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.

Recruiting
NCT05997927Phase 2

Efficacy and Safety Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis

Completed
NCT05814939Phase 2

Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.

Completed
NCT05874622Phase 1

A Phase I Clinical Study of VC005 Tablets in Subjects With Rheumatoid Arthritis.

Completed
NCT05354752Phase 1

Multiple-dose Escalation Clinical Study of VC005 Tablets in Healthy Subjects

Completed
NCT05138770Phase 1

Pharmacokinetics and Pharmacodynamics Clinical Study of VC005 Tablets in Healthy Subjects

Completed

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13